{"title":"Standard Dermatoscope Images vs an Autonomous Total Body Photography and Dermoscopic Imaging Device.","authors":"Pau Rosés-Gibert, Cristina Heras, Narcis Ricart, Enric Campmol, Núria Ferrera, Susana Puig, J Malvehy","doi":"10.1001/jamadermatol.2025.0565","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Recent advancements in autonomous medical devices for skin imaging offer the potential to improve the efficiency and quality of total body photography (TBP) and dermatoscopic documentation, which are essential in treating patients with skin cancer, especially those with high-risk melanoma with atypical mole syndrome.</p><p><strong>Objective: </strong>To compare the image quality and time efficiency of an autonomous TBP and dermoscopic device for TBP and dermoscopic imaging with traditional manual digital dermoscopic techniques.</p><p><strong>Design, setting, and participants: </strong>A prospective cohort study was conducted from March 1, 2023, to October 30, 2023, comparing image quality and time efficiency between an autonomous TBP and dermoscopic device and manual dermoscopic documentation across 316 patients with atypical mole syndrome at 2 dermatology clinics in Spain. All analyses took place in June 2024.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was the acceptability of the images, assessed by 2 independent dermatologists. Secondary outcomes included diagnostic agreement between the 2 methods and time efficiency for image acquisition.</p><p><strong>Results: </strong>Overall, mean (SD) age of patients was 47.13 (3.31) years. The number of male patients was 105 (33%), while the number of female patients was 211 (66%). The autonomous TBP and dermoscopic device produced dermoscopic images with a mean (SD) quality score of 9.84 (0.72), compared with 9.44 (0.85) for manual digital dermoscopy, with no significant differences by body site or lesion type. Diagnostic classification agreement between the 2 methods was 91.60%, with most discrepancies related to small benign lesions. The mean (SD) imaging time for the autonomous device was 570 (169) seconds, compared with 606 (286) seconds for the manual method.</p><p><strong>Conclusions and relevance: </strong>This cohort study found that the autonomous TBP and dermoscopic device produced images of comparable quality to standard dermoscopic techniques while operating with greater time efficiency. These findings suggest that the device may contribute to clinical workflow optimization in dermatology by supporting TBP and dermoscopic imaging.</p>","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":""},"PeriodicalIF":11.5000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamadermatol.2025.0565","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Importance: Recent advancements in autonomous medical devices for skin imaging offer the potential to improve the efficiency and quality of total body photography (TBP) and dermatoscopic documentation, which are essential in treating patients with skin cancer, especially those with high-risk melanoma with atypical mole syndrome.
Objective: To compare the image quality and time efficiency of an autonomous TBP and dermoscopic device for TBP and dermoscopic imaging with traditional manual digital dermoscopic techniques.
Design, setting, and participants: A prospective cohort study was conducted from March 1, 2023, to October 30, 2023, comparing image quality and time efficiency between an autonomous TBP and dermoscopic device and manual dermoscopic documentation across 316 patients with atypical mole syndrome at 2 dermatology clinics in Spain. All analyses took place in June 2024.
Main outcomes and measures: The primary outcome was the acceptability of the images, assessed by 2 independent dermatologists. Secondary outcomes included diagnostic agreement between the 2 methods and time efficiency for image acquisition.
Results: Overall, mean (SD) age of patients was 47.13 (3.31) years. The number of male patients was 105 (33%), while the number of female patients was 211 (66%). The autonomous TBP and dermoscopic device produced dermoscopic images with a mean (SD) quality score of 9.84 (0.72), compared with 9.44 (0.85) for manual digital dermoscopy, with no significant differences by body site or lesion type. Diagnostic classification agreement between the 2 methods was 91.60%, with most discrepancies related to small benign lesions. The mean (SD) imaging time for the autonomous device was 570 (169) seconds, compared with 606 (286) seconds for the manual method.
Conclusions and relevance: This cohort study found that the autonomous TBP and dermoscopic device produced images of comparable quality to standard dermoscopic techniques while operating with greater time efficiency. These findings suggest that the device may contribute to clinical workflow optimization in dermatology by supporting TBP and dermoscopic imaging.
期刊介绍：
JAMA Dermatology is an international peer-reviewed journal that has been in continuous publication since 1882. It began publication by the American Medical Association in 1920 as Archives of Dermatology and Syphilology. The journal publishes material that helps in the development and testing of the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery.
JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. It is published online weekly, every Wednesday, and in 12 print/online issues a year. The mission of the journal is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, with the aim of enabling dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care.
The journal publishes a broad range of innovative studies and trials that shift research and clinical practice paradigms, expand the understanding of the burden of dermatologic diseases and key outcomes, improve the practice of dermatology, and ensure equitable care to all patients. It also features research and opinion examining ethical, moral, socioeconomic, educational, and political issues relevant to dermatologists, aiming to enable ongoing improvement to the workforce, scope of practice, and the training of future dermatologists.
JAMA Dermatology aims to be a leader in developing initiatives to improve diversity, equity, and inclusion within the specialty and within dermatology medical publishing.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
